ScopeConsult ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  6.0% 6.1% 11.1% 11.7% 4.4%  
Credit score (0-100)  39 37 21 19 47  
Credit rating  BBB BBB BB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  1,231 1,133 1,067 1,175 1,174  
EBITDA  512 407 270 611 349  
EBIT  423 320 187 552 297  
Pre-tax profit (PTP)  421.1 317.6 185.4 552.6 296.3  
Net earnings  327.8 248.3 146.0 427.5 229.8  
Pre-tax profit without non-rec. items  421 318 185 553 296  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  212 125 41.7 242 190  
Shareholders equity total  649 568 214 491 621  
Interest-bearing liabilities  127 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,341 930 522 726 864  

Net Debt  -718 -111 -204 -244 -316  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,231 1,133 1,067 1,175 1,174  
Gross profit growth  120.7% -8.0% -5.8% 10.1% -0.1%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,341 930 522 726 864  
Balance sheet change%  177.0% -30.7% -43.8% 39.0% 19.0%  
Added value  512.2 406.9 270.5 636.0 348.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -178 -175 -167 141 -104  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  34.4% 28.2% 17.5% 47.0% 25.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  46.4% 28.2% 25.8% 88.5% 37.4%  
ROI %  69.5% 47.3% 47.9% 154.2% 52.5%  
ROE %  67.5% 40.8% 37.4% 121.3% 41.3%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  48.4% 61.0% 40.9% 67.6% 71.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -140.2% -27.2% -75.4% -39.9% -90.6%  
Gearing %  19.5% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  1.7% 3.1% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.6 2.2 1.6 2.2 2.9  
Current Ratio  1.6 2.2 1.6 2.2 2.9  
Cash and cash equivalent  844.9 110.8 203.9 244.0 315.8  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  444.1 442.4 171.8 261.2 442.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0